Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.1
(-0.19%)
CNY 16.1
(-0.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 880.39 Million CNY | 60.86% |
| 2022 | 926.16 Million CNY | 15.36% |
| 2021 | 802.86 Million CNY | 32.93% |
| 2020 | 603.99 Million CNY | 14.97% |
| 2019 | 525.34 Million CNY | 29.75% |
| 2018 | 404.87 Million CNY | 8.64% |
| 2017 | 372.69 Million CNY | -13.96% |
| 2016 | 433.17 Million CNY | 16.51% |
| 2015 | 371.77 Million CNY | 16.11% |
| 2014 | 320.2 Million CNY | 8.97% |
| 2013 | 293.85 Million CNY | 23.29% |
| 2012 | 238.33 Million CNY | 24.65% |
| 2011 | 191.2 Million CNY | 12.34% |
| 2010 | 170.19 Million CNY | 23.83% |
| 2009 | 137.45 Million CNY | 23.17% |
| 2008 | 111.59 Million CNY | 47.7% |
| 2007 | 75.55 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 284.03 Million CNY | 6.57% |
| 2024 Q3 | 212.75 Million CNY | -24.08% |
| 2024 Q1 | 266.52 Million CNY | -13.12% |
| 2023 Q1 | 235.14 Million CNY | 8.09% |
| 2023 Q4 | 306.78 Million CNY | 52.84% |
| 2023 Q3 | 200.73 Million CNY | -17.46% |
| 2023 Q2 | 243.18 Million CNY | 3.42% |
| 2023 FY | 1.48 Billion CNY | 60.86% |
| 2022 Q1 | 230.9 Million CNY | 10.24% |
| 2022 FY | 926.16 Million CNY | 15.36% |
| 2022 Q4 | 217.55 Million CNY | -9.39% |
| 2022 Q3 | 240.1 Million CNY | 1.05% |
| 2022 Q2 | 237.6 Million CNY | 2.9% |
| 2021 FY | 802.86 Million CNY | 32.93% |
| 2021 Q4 | 209.45 Million CNY | 1.36% |
| 2021 Q3 | 206.63 Million CNY | 4.98% |
| 2021 Q2 | 196.82 Million CNY | 3.62% |
| 2021 Q1 | 189.95 Million CNY | 21.06% |
| 2020 FY | 603.99 Million CNY | 14.97% |
| 2020 Q3 | 177.29 Million CNY | 13.45% |
| 2020 Q1 | 113.51 Million CNY | -25.78% |
| 2020 Q2 | 156.27 Million CNY | 37.67% |
| 2020 Q4 | 156.9 Million CNY | -11.5% |
| 2019 Q2 | 130.02 Million CNY | 21.04% |
| 2019 FY | 525.34 Million CNY | 29.75% |
| 2019 Q3 | 134.96 Million CNY | 3.8% |
| 2019 Q4 | 152.94 Million CNY | 13.32% |
| 2019 Q1 | 107.42 Million CNY | -8.67% |
| 2018 Q3 | 86.05 Million CNY | -22.49% |
| 2018 FY | 404.87 Million CNY | 8.64% |
| 2018 Q2 | 111.02 Million CNY | 23.13% |
| 2018 Q4 | 117.62 Million CNY | 36.68% |
| 2018 Q1 | 90.17 Million CNY | 14.29% |
| 2017 Q4 | 78.9 Million CNY | -8.21% |
| 2017 Q3 | 85.95 Million CNY | -24.05% |
| 2017 Q1 | 94.67 Million CNY | -14.83% |
| 2017 FY | 372.69 Million CNY | -13.96% |
| 2017 Q2 | 113.16 Million CNY | 19.54% |
| 2016 Q2 | 133.22 Million CNY | 29.79% |
| 2016 FY | 433.17 Million CNY | 16.51% |
| 2016 Q4 | 111.15 Million CNY | 29.01% |
| 2016 Q1 | 102.64 Million CNY | 5.21% |
| 2016 Q3 | 86.15 Million CNY | -35.33% |
| 2015 Q4 | 97.56 Million CNY | 10.06% |
| 2015 FY | 371.77 Million CNY | 16.11% |
| 2015 Q3 | 88.64 Million CNY | -4.73% |
| 2015 Q2 | 93.05 Million CNY | 0.58% |
| 2015 Q1 | 92.51 Million CNY | -3.05% |
| 2014 Q4 | 95.42 Million CNY | 27.98% |
| 2014 Q3 | 74.56 Million CNY | -0.98% |
| 2014 FY | 320.2 Million CNY | 8.97% |
| 2014 Q1 | 74.01 Million CNY | -12.62% |
| 2014 Q2 | 75.29 Million CNY | 1.73% |
| 2013 Q4 | 84.71 Million CNY | 19.15% |
| 2013 FY | 293.85 Million CNY | 23.29% |
| 2013 Q3 | 71.09 Million CNY | -1.36% |
| 2013 Q2 | 72.07 Million CNY | 9.27% |
| 2013 Q1 | 65.96 Million CNY | -1.06% |
| 2012 Q4 | 66.66 Million CNY | 4.97% |
| 2012 Q3 | 63.5 Million CNY | 12.67% |
| 2012 Q2 | 56.36 Million CNY | 8.83% |
| 2012 FY | 238.33 Million CNY | 24.65% |
| 2012 Q1 | 51.79 Million CNY | -8.57% |
| 2011 Q3 | 48.16 Million CNY | -3.56% |
| 2011 Q1 | 36.07 Million CNY | -32.65% |
| 2011 Q2 | 49.94 Million CNY | 38.43% |
| 2011 Q4 | 56.65 Million CNY | 17.62% |
| 2011 FY | 191.2 Million CNY | 12.34% |
| 2010 FY | 170.19 Million CNY | 23.83% |
| 2010 Q4 | 53.57 Million CNY | 26.27% |
| 2010 Q2 | 48.3 Million CNY | 86.53% |
| 2010 Q3 | 42.42 Million CNY | -12.17% |
| 2010 Q1 | 25.89 Million CNY | 0.0% |
| 2009 FY | 137.45 Million CNY | 23.17% |
| 2008 FY | 111.59 Million CNY | 47.7% |
| 2007 FY | 75.55 Million CNY | 0.0% |